Skip to main content
. Author manuscript; available in PMC: 2023 Jul 27.
Published in final edited form as: Neuropharmacology. 2020 Feb 12;168:108007. doi: 10.1016/j.neuropharm.2020.108007

Fig. 2.

Fig. 2.

OFC inactivation did not significantly influence EtOH self-administration. There were no significant decreases (as measured by paired t-tests) in active nosepokes, infusions, or inactive nosepokes after inactivation of either (A) mOFC (n = 14) or (B) lOFC (n = 16).